Sonitus Medical’s SoundBite hearing system ranks first on Top 10 Medical Innovations for 2010

Sonitus Medical, Inc., a medical device company developing the world's first non-surgical and removable hearing device to transmit sound via the teeth, today announced that technology it developed was ranked #1 on Cleveland Clinic's Top 10 Medical Innovations for 2010. The SoundBite(TM) hearing system is an investigational new bone conduction device intended initially for single sided deafness (SSD), a usually permanent condition.

The 'Top 10' list was unveiled last week during Cleveland Clinic's 2009 Medical Innovation Summit. Selected by a panel of Cleveland Clinic physicians and scientists, the list features a wide range of breakthrough techniques, devices, and therapies that are being developed to treat everything from deafness and Parkinson's disease to pneumonia and sleep disorders.

Among the major criteria that served as the basis for qualifying and selecting the Top 10 Medical Innovations were the following:

  • Have significant potential for short-term clinical impact (either a major improvement in patient benefit or an improved function that enhances healthcare delivery).
  • Have a high probability of success.
  • Have sufficient data available to support its nomination.

"We are thrilled that technology developed by Sonitus Medical came out on top of this broad ranging list of medical innovations," said Amir Abolfathi, CEO of Sonitus Medical. "It is an honor to be recognized by such a leading institution as the Cleveland Clinic. We look forward to our SoundBite hearing system making an impact in the coming year as we plan to complete our clinical trial process so we can better serve the 9 million patients who currently suffer from single sided deafness in the US alone."

Causes of single sided deafness, sometimes called unilateral sensorineural hearing loss, can include sudden hearing loss or sudden deafness, trauma, diseases, infections, or other inner ear problems.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Experimental drug RK-33 shows promise in treating breast cancer bone metastasis